Trial intelligence / Profile preview

Levofloxacin-based Triple Therapy for H. pylori

NCT01575899Phase 4Terminated

Sponsor
Buddhist Tzu Chi General Hospital
Start
Dec 2007
Primary completion
Dec 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of levofloxacin in Helicobacter pylori infection, sponsored by Buddhist Tzu Chi General Hospital. Started Dec 2007; status: terminated.

02

Drugs

levofloxacin
03

Conditions

Helicobacter pylori infection

Beyond the preview

Go deeper on NCT01575899.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01575899.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call